WeVote
Log In

Bill

Bill

GM 547

Submitting for consideration and confirmation to the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances, Gubernatorial Nominee, JAWANA READY, for a term to expire 06-30-2028.

2025 Regular Session

Bill GM 547 confirms Jawana Ready to the Hawai'i Advisory Commission on Drug Abuse, enhancing efforts to tackle drug-related issues and improve public health in Hawaii.

Confirmed. Ayes, 24. Aye(s) with reservations: none. Noes, 0 (none). Excused, 1 (Senator(s) Fevella).
#hawai'iadvisorycommissionondrugabuseandcontrolledsubstances
0
WeVote Research Nonpartisan
Bill Summary · GM 547

Summary of Bill GM 547

Bill Overview

Bill Number: GM 547
Title: Submitting for consideration and confirmation to the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances, Gubernatorial Nominee, Jawana Ready, for a term to expire 06-30-2028.
Status: Confirmed
Introduced: January 23, 2025
Classification: Proclamation
Subject: Hawai'i Advisory Commission on Drug Abuse and Controlled Substances

Purpose and Intent

The primary purpose of Bill GM 547 is to confirm the nomination of Jawana Ready to serve on the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances. This commission plays a crucial role in advising the state on matters related to drug abuse and controlled substances, aiming to enhance public health and safety in Hawaii.

Key Provisions

  • Nominee Confirmation: The bill confirms Jawana Ready's appointment to the commission.
  • Term Duration: The term for the nominee is set to expire on June 30, 2028.
  • Commission Role: The Hawai'i Advisory Commission on Drug Abuse and Controlled Substances is tasked with providing recommendations and guidance on drug-related issues in the state.

Legislative Actions

  • April 14, 2025: The Senate confirmed the nomination with a vote of 24 Ayes, 0 Noes, and 1 Excused (Senator Fevella).
  • April 11, 2025: The nomination was reported from the Health and Human Services (HHS) Committee with a recommendation to advise and consent.
  • April 7, 2025: A public hearing was held by the HHS Committee to discuss the nomination.
  • January 23, 2025: The bill was introduced and referred to the Commerce and Consumer Protection (CPN) Committee.

Impact

The confirmation of Jawana Ready is expected to influence the commission's efforts in addressing drug abuse issues in Hawaii. The commission's work is vital for developing effective policies and programs aimed at reducing drug-related harm in the community.

Conclusion

Bill GM 547 successfully confirms Jawana Ready's appointment to the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances, ensuring that the commission continues to have qualified members who can contribute to addressing drug abuse challenges in the state. The confirmation process reflects the legislative body's commitment to enhancing public health and safety through informed governance.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.